Clinical Trials Directory

Trials / Completed

CompletedNCT05137093

Scratching Validation Study

Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Philips Clinical & Medical Affairs Global · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.

Detailed description

The Philips scratching algorithm has been cross-validated against the gold-standard assessment of scratching. The algorithm has been used in many drug development trials, occasionally as a means of generating secondary endpoints, but most often as a means of generating exploratory endpoints. The purpose of the proposed study is therefore to validate the data generated by the scratching study compared to the gold-standard video-assessment of scratching, in an independent sample of adults with atopic dermatitis and age- and sex-matched controls

Conditions

Interventions

TypeNameDescription
DEVICEActigraphy DevicePatients will wear actigraphy device which detects scratching events.

Timeline

Start date
2021-12-10
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2021-11-30
Last updated
2023-03-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05137093. Inclusion in this directory is not an endorsement.